Clinical Trial Update: Transdermal Lisuride: a Trial for the Treatment of Patients With Restless Legs Syndrome (RLS) [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating transdermal lisuride for restless legs syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Restless Legs Syndrome

Drugs mentioned

• Lisuride transdermal (lisuride)

Snippet

Sponsor: Axxonis Pharma AG | Conditions: Restless Legs Syndrome | Phase 3 | Status: COMPLETED